M. H. Purdy

538 total citations
7 papers, 439 citations indexed

About

M. H. Purdy is a scholar working on Oncology, Hematology and Genetics. According to data from OpenAlex, M. H. Purdy has authored 7 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Hematology and 2 papers in Genetics. Recurrent topics in M. H. Purdy's work include Hematopoietic Stem Cell Transplantation (3 papers), Cancer Treatment and Pharmacology (2 papers) and Glycosylation and Glycoproteins Research (1 paper). M. H. Purdy is often cited by papers focused on Hematopoietic Stem Cell Transplantation (3 papers), Cancer Treatment and Pharmacology (2 papers) and Glycosylation and Glycoproteins Research (1 paper). M. H. Purdy collaborates with scholars based in United States. M. H. Purdy's co-authors include Elizabeth J. Shpall, Salomon M. Stemmer, Scott I. Bearman, Roy B. Jones, MA Bitter, Henry N. Claman, Tyler J. Curiel, Wilbur A. Franklin, P. G. Archer and BJ Bolwell and has published in prestigious journals such as Journal of Clinical Oncology, Stem Cells and Bone Marrow Transplantation.

In The Last Decade

M. H. Purdy

7 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. H. Purdy United States 4 246 224 96 74 59 7 439
C Lynch United States 6 246 1.0× 324 1.4× 104 1.1× 40 0.5× 33 0.6× 6 460
S Murea Germany 11 325 1.3× 237 1.1× 37 0.4× 68 0.9× 139 2.4× 17 529
W. Brugger Germany 9 248 1.0× 207 0.9× 25 0.3× 101 1.4× 127 2.2× 18 463
Bashar Dabbas United States 9 221 0.9× 92 0.4× 95 1.0× 211 2.9× 58 1.0× 22 559
D Warren United States 7 105 0.4× 260 1.2× 138 1.4× 38 0.5× 22 0.4× 12 364
Ricardo Alvarez United States 11 72 0.3× 133 0.6× 58 0.6× 92 1.2× 50 0.8× 20 374
Atsushi Shinagawa Japan 13 208 0.8× 144 0.6× 39 0.4× 142 1.9× 55 0.9× 39 446
M. M. Uttenreuther-Fischer Germany 13 101 0.4× 198 0.9× 67 0.7× 201 2.7× 143 2.4× 24 542
Sabrina Coluzzi Italy 7 127 0.5× 111 0.5× 267 2.8× 275 3.7× 56 0.9× 7 584
K Schiffman United States 8 605 2.5× 456 2.0× 34 0.4× 125 1.7× 212 3.6× 8 851

Countries citing papers authored by M. H. Purdy

Since Specialization
Citations

This map shows the geographic impact of M. H. Purdy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. H. Purdy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. H. Purdy more than expected).

Fields of papers citing papers by M. H. Purdy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. H. Purdy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. H. Purdy. The network helps show where M. H. Purdy may publish in the future.

Co-authorship network of co-authors of M. H. Purdy

This figure shows the co-authorship network connecting the top 25 collaborators of M. H. Purdy. A scholar is included among the top collaborators of M. H. Purdy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. H. Purdy. M. H. Purdy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Verschraegen, Claire F., et al.. (2007). Phase I/II study of docetaxel (D), gemcitabine (G), and bevacizumab (B) in patients (pts) with advanced or recurrent soft tissue sarcoma (STS). Journal of Clinical Oncology. 25(18_suppl). 10056–10056. 2 indexed citations
2.
Vogel, C. L., et al.. (2004). Safety of zoledronic acid in patients who have previously received bisphosphonate therapy. Journal of Clinical Oncology. 22(14_suppl). 8156–8156. 1 indexed citations
3.
4.
Stemmer, Salomon M., Pablo J. Cagnoni, Elizabeth J. Shpall, et al.. (1996). High-dose paclitaxel, cyclophosphamide, and cisplatin with autologous hematopoietic progenitor-cell support: a phase I trial.. Journal of Clinical Oncology. 14(5). 1463–1472. 53 indexed citations
5.
6.
Shpall, Elizabeth J., Roy B. Jones, SI Bearman, et al.. (1994). Transplantation of CD34+ marrow and/or PBPCS into breast cancer patients following high-dose chemotherapy. Bone Marrow Transplantation. 14. 1 indexed citations
7.
Shpall, Elizabeth J., Scott I. Bearman, Salomon M. Stemmer, et al.. (1993). Positive selection of CD34+hematopoietic progenitor cells for transplantation. Stem Cells. 11(S3). 48–49. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C Lynch Breakdown of academic impact, for papers by S Murea Breakdown of academic impact, for papers by W. Brugger Breakdown of academic impact, for papers by Bashar Dabbas Breakdown of academic impact, for papers by D Warren Breakdown of academic impact, for papers by Ricardo Alvarez Breakdown of academic impact, for papers by Atsushi Shinagawa Breakdown of academic impact, for papers by M. M. Uttenreuther-Fischer Breakdown of academic impact, for papers by Sabrina Coluzzi Breakdown of academic impact, for papers by K Schiffman
Rankless by CCL
2026